Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
BLISSGVS
BLISSGVS

Bliss GVS Pharma Ltd.

NSE: BLISSGVS
BSE: 506197
Sector: Healthcare
Industry: Pharmaceuticals
483.50-21.5 (-4.25%)
17 Jul, 12:00 AM

Stock Scores

Quality Score

76.6 / 100

Value Score

28.2 / 100

Price Momentum Score

96.9 / 100

QVM Score

84.0 / 100

Key Metrics

Market Cap
5136.90
P/E (TTM)
39.78
P/B
4.31
P/S (TTM)
5.54
EV/EBITDA
30.06
CAPE (5Y)
68.66
ROE (TTM)
11.51
ROCE (TTM)
10.73
ROA (TTM)
9.25
Avg 3Y ROE
9.34
Earnings 3Y CAGR
21.33
Sales 3Y CAGR
7.25
Sales 5Y CAGR
9.94
Debt/Equity
0.02
Consensus TP
-
Strong Buy %
-
Promoter Holding
35.36
Pledged %
0.00

Share Price

Track Bliss GVS Pharma Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -7.78 %
Low
479.0
High
535.0
1 Month returns: 1.82 %
Low
455.4
High
553.0
1 Year returns: 208.83 %
Low
118.0
High
553.0
3 Year CAGR: 68.26 %
Low
77.3
High
553.0
5 Year CAGR: 33.67 %
Low
66.1
High
553.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Bliss GVS Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Bliss GVS Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Bliss GVS Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Bliss GVS Pharma Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Bliss GVS Pharma Ltd.?
The current share price of Bliss GVS Pharma Ltd. is ₹ 483.50 as of 17 Jul 2026.
What is the market capitalisation of Bliss GVS Pharma Ltd.?
The market capitalisation of Bliss GVS Pharma Ltd. stands at ₹ 5,136.90 Cr.
What is the PE ratio of Bliss GVS Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Bliss GVS Pharma Ltd. is 39.78 as of the latest trailing twelve months data.
What is the ROE and ROCE of Bliss GVS Pharma Ltd.?
Bliss GVS Pharma Ltd. has a Return on Equity (ROE) of 11.51% and a Return on Capital Employed (ROCE) of 10.73% as per the latest financial reports.
What is the 52-week high and low of Bliss GVS Pharma Ltd.?
The 52-week high of Bliss GVS Pharma Ltd. is - and the 52-week low is -.
What is the dividend yield of Bliss GVS Pharma Ltd.?
The dividend yield of Bliss GVS Pharma Ltd. is 0.21% based on the current market price.
What is the FII and DII holding in Bliss GVS Pharma Ltd.?
Foreign Institutional Investors (FII) hold 10.45%, Domestic Institutional Investors (DII) hold 4.33% and retail/public investors hold 39.71% of Bliss GVS Pharma Ltd. shares.
What sector does Bliss GVS Pharma Ltd. belong to?
Bliss GVS Pharma Ltd. operates in the Healthcare sector.
What is the beta of Bliss GVS Pharma Ltd.?
The beta of Bliss GVS Pharma Ltd. is 1.20, indicating its price volatility relative to the broader market. Over the past 1 year, Bliss GVS Pharma Ltd. has delivered an absolute return of 210.00%.
What is the RSI of Bliss GVS Pharma Ltd.?
The 14-day Relative Strength Index (RSI) of Bliss GVS Pharma Ltd. is 50.32, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.